Skip to Main Content
CWRU Links

2012 Articles

November 19, 2012

Date Released: 19 November 2012
News Banner


Stem Cells' Promise Hits Funding Wall in Michigan
Detroit Free Press - Nov 17, 2012
But even with those exceptions, Dr. Stanton Gerson, director of the NCRM, sees bioscience as a way to re-ignite business -- even outside the ...

Stem Cell Therapy: What Physicians Should Know
MD News - Nov 16, 2012
And there's more, much more, according to Stanton Gerson, MD, director of UH Seidman Cancer Center and the Case Comprehensive Cancer Center, and Marcos JG de Lima, MD, director of UH Seidman's Hematologic Malignancies and Stem Cell Transplant Program which focuses on non-embryonic stem cells.

Breast Cancer Vaccine Researcher Vincent Tuohy Gets $1 Million Gift 
Plain Dealer - Nov 15, 2012
Vincent Tuohy, an immunologist at the Clinic's Lerner Research Institute, is the beneficiary of the Mort and Iris November Distinguished Chair in Innovative Breast Cancer Research, created through a $1 million endowment given by the couple

Options Shifting for First-line Treatment of Renal Cell Carcinoma
ASCO Post - Nov 15, 2012
"Kidney cancer is fundamentally a VEGF-driven disease," noted Brian R. Rini, MD, of the Department of Solid Tumor Oncology, Cleveland Clinic Taussig Cancer Institute, and Glickman Urologic and Kidney Institute.


Friends For An Earlier Breast Cancer Test

Friends For An Earlier Breast Cancer Test, a non-profit organization dedicated to promoting awareness and education and to raising funds for research into earlier detection of breast cancer, is requesting applications for pilot projects that focus on new methods to improve detection of early breast cancer. This organization is especially interested in the development of new techniques in the areas of biological or immunologic methods of early detection, with the hope that pilot projects will provide preliminary data that leads to applications for more substantial peer-reviewed funding.

Deadline: December 1


Miltenyi Biotec Seminar and Machine Demonstration

A representative from Miltenyi Biotec will be on campus Thursday, November 29 to give a seminar discussion and live demonstration of a new machine they have developed for aiding in the digestion and dissociation of tumor tissue for growing cells ex vivo, called the gentleMACS. Learn how MACS® Technology provides unique, reliable, and convenient solutions for your research. The combined product portfolio offers an unrivaled resource for researchers: from tissue dissociation through cell isolation, cell culture and analysis, to small animal preclinical imaging. Discover solutions optimized to deliver outstanding results while saving you time.

Brian Kierce, Miltenyi Biotec District Sales Manager, will present, Tissue dissociation and downstream magnetic cell isolation technologies, at 11 am in Wolstein Research Building 2-136. He will also be available to give live demonstrations of the machine later in the day. If anyone would like to try out the machine using their favorite tumor/tissue, or see the machine in action please contact Kristy Miskimen (216.368.5363,

So You Want To Do Comparative Effectiveness Research? The Nuts and Bolts of CER

Registration is open for So You Want To Do Comparative Effectiveness Research? The Nuts and Bolts of CER, to be held Friday, December 14 in the WRB Auditorium. This half-day symposium will help heighten the understanding of comparative effectiveness research (CER), identify strategies to evaluate competing treatments and highlight the various research design methods available to perform CER. The course will be taught at an introductory level and is designed to provide resources for investigators to pursue future research projects. There is $25 registration fee, though this fee is waived for trainees, scholars, and K awardees.

CER is defined as the direct comparison of existing health care interventions to determine which work best for which patients and which pose the greatest benefits and harms. CER is receiving increasing importance nationally and internationally as a priority area of investigation and has led to the establishment of the Patient-Centered Outcomes Research Institute (PCORI).


Case CCC Clinical Trials Admin Staff Hold Office Hours at the Cleveland Clinic

Case CCC clinical trials administrative staff is now holding office hours at the Cleveland Clinic in JJN2-326:

  • April Firstencel, Registration Coordinator for and NCI/CTRP
    Cleveland Clinic office hours: Thursdays 8:30 am-5 pm
  • David Goldblatt, Protocol Review & Monitoring Committee Manager
    Cleveland Clinic office hours: Fridays 9 am-3 pm

Please feel free to stop by their office in the JJ building with any questions regarding PRMC,, NCI/CTRP and OnCore issues.

Cancer Care Video Challenge

The Office of the National Coordinator for Health Information Technology (ONC) in conjunction with the National Cancer Institute (NCI), invites cancer patients, survivors, and their families and friends to create short, compelling videos sharing a personal story that describes a goal of a cancer patient or survivor, and how technology (such as health IT or consumer eHealth tools) is used to support meeting that goal. There are a variety of tools and applications that can be used to help patients and their families navigate the various aspects of living with or transitioning from cancer treatment to survivorship.

The purpose of the challenge is to generate videos that will inspire and motivate others to become more engaged in their care, through the use of consumer e-health tools and other health IT to improve communication and collaboration with their health care team (doctors, nurses, and other allied health care professionals), and better manage their cancer-related care.

The deadline to submit a video is December 21. Cash prizes are available to the winners.


November 13, 2012

Featured Article: Study Shows Importance of Early End-of-Life Care Discussions

Drug May Reduce Cognitive Decline Following Radiation for Brain Metastases

Brazil's Strong Antismoking Policies Credited with Saving Lives

Possible Cause of Doxorubicin-Induced Heart Damage Identified

Study Reveals New Mechanism of Action for Class of Targeted Therapy

Also in the News: Radium-223 Improves Survival in Men with Metastatic Prostate Cancer

Also in the Journals: Genetic Factors Linked to Lung Cancer in Asian Women Who Have Never Smoked

NIH Research Radio: A Clinical Trial for HIV-Positive Cancer Patients

In Depth
Decades Later, Chernobyl Accident Yields Clues to Leukemia Risk

Featured Clinical Trial: Dietary Intervention for Patients Receiving Chemoradiotherapy for Lung Cancer

DREAMing Big to Solve Cancer Research Challenges

FDA Update: New Treatment Approved for Chronic Myelogenous Leukemia

CDC Update: Global Study Documents Tobacco Use, Secondhand Smoke Exposure among Women of Childbearing Age Update: Newly Launched NCI Map Stories Show Geographic Patterns of Cancer




November 19

Cancer Center Chalk Talk
Lyndsay Harris, MD
Professor, Medicine-Hematology/Oncology
Topic: TBD
12 pm WRB 3-136

Immunology Invited Speaker Seminar Series
Xiaoyu Hu, MD, PhD
Assistant Professor, Immunology
Cornell University
Topic: Regulation of Inflammation by Notch Signaling
1:30 pm NC1-202 Cleveland Clinic

Sequencing Data Interest Group
Yaomin Xu, PhD
Assistant Professor, Statistical Genetics and Bioinformatics
CWRU/Cleveland Clinic
Topic: Reproducible Analysis on NGS Epigenomic Data
2:30 pm WRB 1-402

Physiology and Biophysics Seminar
William Evans, PhD
Vice President and Head, Muscle Metabolism Discovery Performance Unit
Topic: Skeletal Muscle as a Target for Drug Discovery: New Indications for Aging and Cachexia
4 pm SOM E501

Skeletal Research Center
Justin Lathia, PhD
Assistant Professor, Cell Biology
CWRU/Cleveland Clinic
Topic: Holding on to Stemness: Interrogating Adhesion Mechanisms in the Perivascular Niche that Instruct Brain Tumor Stem Cells
4 pm Millis 123

November 20

Radiation Oncology Physics Seminar
Peter Park
PhD Candidate, Medical Physics
University of Texas MD Anderson Cancer Center
Topic: How to Cope With Uncertainties in Proton Therapy: Current and Future Prospect
8 am Lerner B-151

Medicine Grand Rounds
Wendy Levinson, MD
Professor and Chair, Medicine
University of Toronto
Topic: Professionalism in Health Care: A Novel and Practical Approach for Physicians and Teams
12 pm Kulas Auditorium, Lakeside 5th Fl.

November 21

Hematology and Oncology Research Conference canceled

November 22

Happy Thanksgiving!

November 23

Cancer Center Research in Progress canceled

Cancer Center Seminar Series canceled

Hematology/Oncology Fellows Conference/Curriculum Series

Taussig Cancer Institute Grand Rounds canceled

Case CCC Calendar

LRI Calendar




The Cancer Genome Atlas 2nd Annual Scientific Symposium: Enabling Cancer Research Through TCGA
November 27-28
Crystal City, Virginia

American Society of Hematology (ASH) Annual Meeting
December 8-11
Atlanta, Georgia

So You Want To Do Comparative Effectiveness Research? The Nuts and Bolts of CER
December 14
7:30 am - 12 pm WRB 1-413

Pacific Symposium on Biocomputing 2013
January 3-7, 2013
Fairmont Orchid, Hawaii


AACR Dharma Master Jiantai Innovative Grant for Lung Cancer Research
Deadline: November 20

Landon Foundation-AACR INNOVATOR Award for Cancer Prevention Research
Deadline: November 20

Limited Submission: NIH Director's Early Independence Award
Internal Deadline: November 26
LOI Deadline: December 30
Full Application: January 30, 2013

Limited Submission: Rita Allen Foundation Scholars Program
Internal Deadline: November 26
External Deadline: January 25, 2013

AACR Minority Scholar in Cancer Research Award
Deadline: November 30

AACR-Thomas J. Bardos Science Education Awards for Undergraduate Students
Deadline: November 30

AACR-Women in Cancer Research (WICR) Scholar Awards
Deadline: November 30

AACR-National Brain Tumor Society Career Development Award for Translational Brain Tumor Research
Deadline: November 30

Alex's Lemonade Stand Foundation Innovation Grants
Deadline: December 3

Conquer Cancer Foundation of ASCO Medical Student Rotation for Underrepresented Populations
Deadline: December 3

Weatherhead Institute for Family Medicine and Community Health Pilot
Deadline: December 3

DOD Breast Cancer Research Program Postdoctoral Fellowship Award
Pre-Application Deadline: December 4
Application Deadline: December 18

CTSC Explorys Collaborative Pilots
Deadline: December 14

Alex's Lemonade Stand Foundation Epidemiology Awards
Deadline: December 17

Alex's Lemonade Stand Foundation Young Investigator Awards
Deadline: December 17

Association for Research of Childhood Cancer
Deadline: January 1, 2013

2013 CTSC Annual Pilot Grant Funding
LOI Deadline: January 15, 2013

Translational Technology Concept Studies of Circulating Tumor and Endothelial Cells (CTC/CEC)
Deadline: Open

AACR Scholar-in-Training Awards - Other Conferences and Meetings
Deadline: Open

Case CCC Protocol Specific Research Support (PSRS)
Deadline: Open

International Union Against Cancer (UICC) International Cancer Technology Transfer Fellowships
Application Deadline: Open

International Waldenstrom's Macroglobulinemia Foundation (IWMF) Research Grant Program
Application Deadline: Open

James S. McDonnell Foundation Collaborative Activity Awards
Deadline: Open

NCI Short-Term Scientist Exchange Program
Application Deadline: Open

SAIC-Frederick Support of the Cancer Genome Atlas Program
Application Deadline: Open

Solving Kids' Cancer Therapeutic Development Initiative
Application Deadline: Open

NIH BULLETIN – Notices and Funding Opportunities

Administrative Supplements for Research on Sex/Gender Differences (Admin Supp)(PA-13-018)

NCI Mentored Patient-Oriented Research Career Development Award to Promote Diversity (K23)(PAR-12-052)

NCI Mentored Research Scientist Development Award to Promote Diversity (K01)(PAR-12-050)

Validation of Molecular Diagnostics to Predict Patient Outcomes Using Specimens from Multi-Site Cancer Trials (R21)(PA-12-014)

NCI Established Investigator Award in Cancer Prevention and Control (K05)(PAR-12-065)

Validation and Advanced Development of Emerging Molecular Analysis Technologies for Cancer Research (R33)(RFA-CA-13-002)

Validation and Advanced Development of Emerging Technologies for Biospecimen Science (R33)(RFA-CA-13-004)

Early-Stage Innovative Molecular Analysis Technology Development for Cancer Research (R21)(RFA-CA-13-001)

Early-Stage Development of Innovative Technologies for Biospecimen Science (R21)(RFA-CA-13-003)

Biomechanisms of Peripheral Nerve Damage by Anti-Cancer Therapy (R01)(PA-12-082)

Biomechanisms of Peripheral Nerve Damage by Anti-Cancer Therapy (R21 (PA-12-083)

The NCI Transition Career Development Award to Promote Diversity (K22)(PAR-12-06)

Produced by:
Gillian Irwin Todd
11100 Euclid Avenue, Wearn 149
Cleveland, Ohio 44106-5065
216-844-8317 phone
216-844-7832 fax


If you have a new grant, recently won an award, or have other newsworthy items, please let us know so we can publicize them in the newsletter and other media outlets. You deserve the accolades!

Send items to